Hyperbaric Medical Solutions

What Hyperbaric Medical Solutions does

Hyperbaric Medical Solutions (HMS) is a privately held, independent specialty medical clinic operator founded in 2011 in Medford, New York, and currently headquartered in Woodbury, NY. The company delivers hyperbaric oxygen therapy (HBOT) as its core service, using FDA-approved medical-grade monoplace hyperbaric chambers capable of reaching 3.0 ATA at 100% oxygen — a technical configuration materially different from the soft/mild chambers used in wellness settings. HMS operates five clinic locations across three states: Manhattan and Woodbury (New York), Fort Lauderdale and Miami (Florida), and Randolph (Massachusetts).

The company's clinical portfolio extends beyond HBOT into adjacent regenerative and longevity services, including Platelet-Rich Plasma (PRP) therapy, intravenous (IV) therapy, Ketamine therapy, a personalized Longevity program, and a Metabolic Health & Cancer Support program. Patients are treated for two broad indication categories: the 14 FDA-approved on-label conditions (such as radiation tissue damage, diabetic foot ulcers, sudden hearing loss, and chronic refractory osteomyelitis) that are typically reimbursable by major commercial insurers and Medicare, and a longer off-label menu (concussions, TBI, long COVID, Lyme disease, multiple sclerosis, post-surgical recovery, and others) that is paid out-of-pocket or via payment plans.

HMS is physician-led, with double board-certified medical directors overseeing clinical operations. The business model blends insurance reimbursement (for on-label indications) with direct patient payments (for off-label and complementary services), and patient acquisition is driven by specialty-specific physician referral programs spanning nine medical specialties, complemented by direct-to-patient content marketing and a condition-education website. The company is privately held, bootstrapped, and operates without disclosed institutional investment, M&A activity, or public-market presence.

Name

Hyperbaric Medical Solutions

Legal name

Hyperbaric Medical Solutions

Website

https://hyperbaricmedicalsolutions.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Hyperbaric Oxygen Therapy and Wound Care Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Wound Care & Hyperbaric Oxygen Therapy Centers (HLAFABAG)

Keywords

• Hyperbaric oxygen therapy
• Wound care services
• Regenerative medicine
• PRP therapy treatments
• IV therapy services

Headquarters

HQ city

Woodbury

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Services Revenue: Revenue generated from providing hyperbaric oxygen therapy treatments and other regenerative medical services including PRP therapy, IV therapy, metabolic support, longevity programs, and ketamine therapy. Services are billed through insurance reimbursements for FDA-approved conditions and direct patient payments for off-label treatments.
2. Insurance Reimbursements: The company accepts most major insurance plans and receives reimbursements for FDA-approved (on-label) HBOT conditions. This includes plans such as Aetna, Cigna, Empire Blue Cross, Medicare, Oxford, United Healthcare, and others across different state locations.
3. Patient Out-of-Pocket Payments: Revenue from patients paying out-of-pocket for off-label conditions not covered by insurance, as well as copays, deductibles, and coinsurance for covered conditions. Payment plans and financial assistance programs are available.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Hyperbaric Medical Solutions operates physician-led medical clinics providing hyperbaric oxygen therapy (HBOT) using FDA-approved monoplace chambers as its core treatment, supplemented by complementary regenerative services including PRP therapy, IV therapy, a Longevity Program, Metabolic Health & Cancer Support, and Ketamine Therapy. Treatments are delivered across five clinic locations in New York, Florida, and Massachusetts, serving both insurance-covered FDA-approved indications and self-pay off-label conditions.

Product overview

Hyperbaric Medical Solutions operates as a unified medical clinic offering hyperbaric oxygen therapy as its primary treatment modality alongside complementary regenerative services. The core HBOT treatment is delivered through state-of-the-art monoplace hyperbaric chambers at five locations, which serves as the foundation of their clinical protocols. This core service is supplemented by PRP Therapy, IV Therapy, a Longevity Program, Metabolic Health & Cancer Support, and Ketamine Therapy—all designed to integrate with and enhance the primary HBOT treatment outcomes. The company positions itself as offering personalized, physician-guided regenerative care that combines multiple treatment modalities in customized care plans.

Differentiator

Problem solved

Functional benefit

Products and services

• Hyperbaric Oxygen Therapy (HBOT) All-natural, non-invasive treatment in which patients breathe 100% medical-grade oxygen inside an FDA-approved monoplace hyperbaric chamber at increased atmospheric pressure (up to 3.0 ATA), boosting body oxygen concentration by up to 1,200% to fuel cellular repair, stimulate angiogenesis, improve circulation, and encourage stem cell release.
• PRP Therapy Platelet-Rich Plasma regenerative treatment that uses concentrated platelets from the patient's own blood to activate natural growth factors and attract circulating stem cells, reducing inflammation and accelerating recovery for arthritis, tendon injuries, and sports-related conditions.
• IV Therapy Intravenous therapy that delivers vitamins, minerals, antioxidants, and electrolytes directly into the bloodstream for 100% absorption (versus approximately 30% absorption with oral supplements), providing near-instant results.
• Longevity Program Personalized longevity programs designed to address biological processes that influence aging through guided, consultative protocols tailored to each patient's unique biology.
• Metabolic Health & Cancer Support Program Non-toxic cancer support program focused on early-stage cancers (such as breast, prostate, and brain cancer) using a terrain-based approach with non-toxic therapies intended to strengthen the immune system.
• Ketamine Therapy Therapeutic ketamine treatment offered as part of HMS's regenerative medicine service portfolio.

Quantifiable outcome

• Oxygen concentration increase in the body by up to 1,200%
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• RestorixHealth: Operates wound care and hyperbaric oxygen therapy centers across the US via hospital outpatient partnerships and independent clinics. Directly comparable to HMS's core model of delivering HBOT and wound care services through multi-site specialty clinics.
• Healogics: Largest US provider of advanced wound care services, operating hundreds of hospital outpatient wound care centers that incorporate HBOT. Comparable to HMS in clinical modality, payer relationships, and referral-driven patient acquisition.
• Aviv Clinics: Operates medical-grade HBOT clinics focused on cognitive, longevity, and performance applications. Closely comparable to HMS in chamber specifications, off-label/longevity use cases, and premium physician-led positioning.
• Wound Care Advantage: Consulting and management company for hospital-affiliated wound care and hyperbaric programs. Comparable to HMS in clinical focus on the FDA-approved wound care HBOT indications and in supporting multi-site operations.
• CūtisCare: Manages wound care and hyperbaric oxygen therapy programs across hospitals and outpatient settings. Directly comparable to HMS in service mix and physician-referral GTM targeting the same on-label indications.

Emerging players

• Ketamine Wellness Centers: Operates outpatient specialty clinics delivering therapeutic ketamine infusions. Comparable to HMS as a direct-pay outpatient specialty clinic operator that supplements core service lines (ketamine at HMS) with integrative wellness offerings.
• Restore Hyper Wellness: Retail-franchised recovery and wellness chain offering IV therapy, cryotherapy, and mild hyperbaric. Comparable to HMS's IV therapy and recovery add-ons and competes for the same consumer-discretionary patient segment.

Others

• OxyHealth: Manufacturer and global distributor of portable hyperbaric chambers, including soft/medical-grade units. Comparable to HMS as a critical supplier of HBOT chamber technology underpinning clinic operations.

Broad incumbents

• Mayo Clinic Hyperbaric Medicine: Runs one of the largest hospital-based HBOT programs in the US, treating the full on-label condition set within an academic medical center. Comparable to HMS in clinical scope but competes as an embedded hospital option that can absorb physicians and referrals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/hmshbot
• Facebookfacebook.com/HyperbaricMedicalSolutions
• LinkedInlinkedin.com/company/hyperbaric-medical-solutions

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hyperbaric Medical Solutions